NCT00626782 - Lucentis Versus Mitomycin C During Glaucoma Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Glaucoma

Interventions

DRUG

Ranibizumab

Ranibizumab 0.5mg (0.05mL)one injection in sub-tenon's at the conclusion of glaucoma surgery

DRUG

Mitomycin (MMC)

Mitomycin (MMC) C 0.4 mg/ml applied with soaked pledget inserted in the sub-tenon's space during glaucoma surgery.

Trial Locations (1)

Wills Eye Hospital, Glaucoma Service, Philadelphia